Showing 1,656 news articles about Hepatitis & HIV

Filters Content type: Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

New & experimental hepatitis C treatment

Achillion Announces 100% SVR12 in the 6-Week and 8-Week Cohorts in Janssen’s Phase 2 Trial Evaluating the Triple Combination Treatment Regimen Including Odalasvir, AL-335, and Simeprevir for Genotype 1 Treatment-Naïve HCV

Editor's pick
Achillion press release
26 September 2016
Hepatitis C treatment

NICE says yes to another hepatitis C drug

Editor's pick
NICE
26 September 2016
Hepatitis C treatment

Exviera, Viekirax regimen shows high SVR in HCV genotype 1b after 8 weeks

Editor's pick
Healio
26 September 2016
Hepatitis C treatment

New Study: Negotiated Hepatitis C Prescription Drug Costs in United States Often Lower than in Price-Controlled European Countries and Japan

Editor's pick
Yahoo News
20 September 2016
Hepatitis C treatment

Behind Battle Over Drug Prices, Quiet Money From Big Pharma

Editor's pick
Bloomberg
19 September 2016
Access to healthcare

NHS funding cuts ‘forcing people to buy medicine through Facebook’

Editor's pick
The Independent
16 September 2016
Hepatitis C treatment

Inventor of Hepatitis C Cure Wins a Major Prize—and Turns to the Next Battle

Editor's pick
Scientific American
13 September 2016
Hepatitis B

ContraVir Reports New CRV431 Data Highlighting Synergistic Activity with CMX157 Against Hepatitis B

Editor's pick
ContraVir press release
12 September 2016
Hepatitis C treatment

Ethiopia unable to provide effective national response to viral hepatitis

Editor's pick
Healio
12 September 2016
Hepatitis C treatment

UK: More options to be made available to treat hepatitis C

Editor's pick
NICE press release
12 September 2016
New & experimental hepatitis C treatment

Achillion Announces 100% SVR Reported in Janssen’s Phase 2a Trial Evaluating Triple Combination of Odalasvir, AL-335, and Simeprevir for Genotype 1 Treatment-Naive HCV

Editor's pick
Achillion press release
9 September 2016
Access to healthcare

Letter to Gilead Sciences on attempts to remove generic sofosbuvir from Ukraine

Editor's pick
MSF
7 September 2016
Hepatitis B

Act now for a Hepatitis-free Indonesia

Editor's pick
Jakarta Post
7 September 2016
Access to healthcare

Doctors Without Borders urges Gilead to rethink its hepatitis C strategy in Ukraine

Editor's pick
STAT
7 September 2016
Hepatitis C treatment

VA estimates 107000 vets have undiagnosed or untreated hepatitis C

Editor's pick
Stars and Stripes
7 September 2016
People who inject drugs

New research supports hep C treatment for people who use drugs

Editor's pick
Eurekalert Medicine & Health
7 September 2016
Access to healthcare

High cost hampers treatment of hepatitis B, C in Vietnam: experts

Editor's pick
Thanh Nien Daily
31 August 2016
Pharmaceutical industry

University of Minnesota sues Gilead Sciences over hepatitis drugs

Editor's pick
Minneapolis Star Tribune
31 August 2016
Pharmaceutical industry

Hillary Clinton calls out drug maker Gilead over price of hepatitis C pills

Editor's pick
UPI.com
19 August 2016
Exposure to HIV through medical procedures

Nottinghamshire dentist Desmond D'Mello struck off by General Dental Council

Editor's pick
BBC Health
19 August 2016
Pharmaceutical industry

German agency criticises European programme for speeding some drug approvals

Editor's pick
STAT
18 August 2016
Hepatitis C treatment

New research supports the removal of drug use as a restriction to hepatitis C treatment

Editor's pick
EurekAlert
15 August 2016
Hepatitis C treatment

European Commission Grants Marketing Authorisation for MSD’s ZEPATIER™ (elbasvir/grazoprevir) for the Treatment of Chronic Hepatitis C Infection

Editor's pick
MSD press release
2 August 2016
Hepatitis C transmission & prevention

22.6m Nigerians suffering from Hepatitis

Editor's pick
Vanguard
2 August 2016